Aic24 Ringeisen Brad

Brad Ringeisen

Executive Director, Innovative Genomics Institute

Brad Ringeisen is the executive director of Innovative Genomics Institute. He guides scientific and development strategy to link the development of gene-editing tools to affordable and accessible solutions in human health and climate. Previously, Ringeisen was director of the Biological Technologies Office at DARPA, overseeing research in genome editing, epigenetics, neurotechnology, food security and biomanufacturing as well as diagnostics and therapeutics development. There, his office was responsible for early investments in mRNA vaccines as well as a discovery platform that isolated one of the first monoclonal antibody treatments used during the COVID-19 pandemic. Prior to this, Ringeisen was the head of the Bioenergy and Biofabrication Section at the U.S. Naval Research Laboratory.

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
aerial 2019 campus
Sign up to receive the latest news from Aspen Ideas.